Minister marks $2bn in price cuts

September 5, 2016 Latest News

This is a preview of subscriber content

Subscribe now to continue reading.

Health Minister Sussan Ley has anticipated 1 October price cuts to 2,000 PBS-listed medicines, describing it as a "win-win" for consumers and taxpayers. …

Subscribe now to continue reading.

Latest Video

New Stories

Moderna taps Salesforce to unify global commercial operations
April 30, 2026 - - Latest News
How do we know the HTA institution loves patients? Because they use a love heart emoji
April 30, 2026 - - Latest News
Australian company secures capital raise to advance amsulostat trials and strengthen pipeline
April 29, 2026 - - Latest News
Australia urged to strengthen sunscreen literacy and label clarity
April 29, 2026 -
'Let me once again explain why we must close the gap for people with cystic fibrosis–related diabetes'
April 29, 2026 - - Latest News
We need to say it again, just in case, that this advice is about ministerial choices and not conditions
April 29, 2026 - - Latest News
Families welcome cancer drug progress but remain cautious over timely access
April 28, 2026 - - Latest News

Minister marks $2bn in price cuts

This is a preview of subscriber content

Latest Video

Most Read

Lilly's Mounjaro will not be listed on PBS because of 'unrealistic' recommendation

Quarter of a century after the case that led to the PBAC's unaccountability loop

Outcomes deliver disappointment for vaccine advocates but progress on paediatric access to biologics

This makes it twice in two weeks, so at what point do we accept there's a problem?

'Let me once again explain why we must close the gap for people with cystic fibrosis–related diabetes'

New Stories

Moderna taps Salesforce to unify global commercial operations

How do we know the HTA institution loves patients? Because they use a love heart emoji

Australian company secures capital raise to advance amsulostat trials and strengthen pipeline

Australia urged to strengthen sunscreen literacy and label clarity

'Let me once again explain why we must close the gap for people with cystic fibrosis–related diabetes'

We need to say it again, just in case, that this advice is about ministerial choices and not conditions

Families welcome cancer drug progress but remain cautious over timely access

Sign In

Minister marks $2bn in price cuts

This is a preview of subscriber content

Latest Video

Most Read

Lilly's Mounjaro will not be listed on PBS because of 'unrealistic' recommendation

Quarter of a century after the case that led to the PBAC's unaccountability loop

Outcomes deliver disappointment for vaccine advocates but progress on paediatric access to biologics

This makes it twice in two weeks, so at what point do we accept there's a problem?

'Let me once again explain why we must close the gap for people with cystic fibrosis–related diabetes'

Follow Us

New Stories

Moderna taps Salesforce to unify global commercial operations

How do we know the HTA institution loves patients? Because they use a love heart emoji

Australian company secures capital raise to advance amsulostat trials and strengthen pipeline

Australia urged to strengthen sunscreen literacy and label clarity

'Let me once again explain why we must close the gap for people with cystic fibrosis–related diabetes'

We need to say it again, just in case, that this advice is about ministerial choices and not conditions

Families welcome cancer drug progress but remain cautious over timely access